Figure 21.
Hazard assessment of thermoplastic composites reinforced with reduced graphene oxide. (A) Characterization of rGO and abraded particles from PA6-rGO composites. SEM images of rGO, abraded particles from PA6-rGO composite and abraded particles from neat PA6. Animals (n = 3) were exposed by oropharyngeal aspiration to abraded polymer (PA6, 15 μg), abraded composite (PA6-rGO, 15 μg; with 2.5% rGO, hence 0.375 μg of rGO in 15 μg of PA6-rGO), reduced graphene oxide (rGO, 0.3 μg or 15 μg; 2.5% of 15 μg equals to about 0.3 μg), or negative control (BSA 0.1% in water). (B) Representative images of hematoxylin and eosin (H&E)-stained lung sections from mice exposed to rGO and abraded composites, following 1, 7, and 28 days after oropharyngeal aspiration. Arrows indicate the formation of granulomas after treatment with rGO.280 Reproduced with permission from Chortarea, S.; Kuru, O. C.; Netkueakul, W.; Pelin, M.; Keshavan, S.; Song, Z.; Ma, B.; Gomes, J.; Abalos, E. V.; Luna, L. A. V.; Loret, T.; Fordham, A.; Drummond, M.; Kontis, N.; Anagnostopoulos, G.; Paterakis, G.; Cataldi, P.; Tubaro, A.; Galiotis, C.; Kinloch, I.; et al. Hazard Assessment of Abraded Thermoplastic Composites Reinforced with Reduced Graphene Oxide. J. Hazard. Mater. 2022, 435, 129053. Copyright 2022, Elsevier.
